Stage IV Colorectal Cancers: An Analysis of Factors Predicting Outcome and Survival in 728 cases

Journal of Gastrointestinal Surgery

Volumn 16, Issue 3, 2012, Pages 603-612

  Chew, Min Hoe ^a   Teo, Jin Yao ^a   Kabir, Tousif ^b   Koh, Poh Koon ^a   Eu, Kong Weng ^a   Tang, Choong Leong ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Colorectal cancer; Curative; Metasectomy; Stage IV

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; COLORECTAL TUMOR; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SINGAPORE; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SINGAPORE; SURVIVAL RATE; YOUNG ADULT;

EID: 84856765071     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-011-1725-1     Document Type: Article

References (20)

1. Scoggins CR, Meszoely IM, Blanke CD, Beauchamp RD, Leach SD. Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann Surg Oncol. 1999; 6(7): 651-7.
2. Kleespies A, Füessl KE, Seeliger H, Eichhorn ME, Müller MH, Rentsch M, Thasler WE, Angele MK, Kreis ME, Jauch KW. Determinants of morbidity and survival after elective non-curative resection of stage IV colon and rectal cancer. Int J Colorectal Dis. 2009; 24(9): 1097-109.
3. Stelzner S, Hellmich G, Koch R, Ludwig K. Factors predicting survival in stage IV colorectal carcinoma patients after palliative treatment: a multivariate analysis. J Surg Oncol. 2005; 89(4): 211-7.
4. Evans MD, Escofet X, Karandikar SS, Stamatakis JD. Outcomes of resection and non-resection strategies in management of patients with advanced colorectal cancer. World J Surg Oncol. 2009; 7: 28.
5. Ruo L, Gougoutas C, Paty PB, Guillem JG, Cohen AM, Wong WD. Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. J Am Coll Surg. 2003; 196(5): 722-8.
6. Cook AD, Single R, McCahill LE. Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: an analysis of surveillance, epidemiology, and end results data, 1988 to 2000. Ann Surg Oncol. 200; 12(8): 637-45.
7. Eisenberger A, Whelan RL, Neugut AI. Survival and symptomatic benefit from palliative primary tumor resection in patients with metastatic colorectal cancer: a review. Int J Colorectal Dis. 2008; 23(6): 559-68.
8. Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual, 7th Ed; 2009.
9. Simmonds PC. Palliative chemotherapy for advanced colorectal cancer: a systematic review and meta-analysis, Colorectal Cancer Collaborative Group. BMJ 2000; 321: 531-535.
10. Petrelli NJ. Systemic chemotherapy should be the primary treatment of synchronous colorectal metastases in the asymptomatic patient. Ann Surg Oncol. 2006; 13(2): 137-139.
11. Damjanov N, Weiss J, Haller DG. Resection of the primary colorectal cancer is not necessary in nonobstructed patients with metastatic disease. Oncologist. 2009; 14(10): 963-9.
12. Tebbutt NC, Norman AR, Cunningham D, Hill ME, Tait D, Oates J, Livingston S, Andreyev J. Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases. Gut. 2003; 52(4): 568-73.
13. Muratore A, Zorzi D, Bouzari H, Amisano M, Massucco P, Sperti E, Capussotti L. Asymptomatic colorectal cancer with un-resectable liver metastases: immediate colorectal resection or up-front systemic chemotherapy? Ann Surg Oncol. 2007; 14(2): 766-70.
14. Benoist S, Pautrat K, Mitry E, Rougier P, Penna C, Nordlinger B. Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases. Br J Surg. 2005; 92(9): 1155-60.
15. Galizia G, Lieto E, Orditura M, et al. First-line chemotherapy vs bowel tumour resection plus chemotherapy for patients with unresectable synchronous colorectal hepatic metastases. Arch Surg. 2008; 143: 352-358.
16. Stelzner S, Hellmich G, Koch R, et al. Factors prediciting survival in stage IV colorectal carcinoma patients after palliative treatment: a multivariate analysis. J Surg Oncol. 2005; 89: 211-217.
17. Yun HR, Lee WY, Lee WS, Cho YB, Yun SH, Chun HK. The prognostic factors of stage IV colorectal cancer and assessment of proper treatment according to the patient's status. Int J Colorectal Dis. 2007; 22(11): 1301-10.
18. van Cutsem E, Rivera F, Berry S, Kretzschmar A, Michael M, DiBartolomeo M, Mazier MA, Canon JL, Georgoulias V, Peeters M, Bridgewater J, Cunningham D, First BEAT investigators. Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study. Ann Oncol. 2009; 20(11): 1842-7.
19. Kozloff M, Yood MU, Berlin J, Flynn PJ, Kabbinavar FF, Purdie DM, Ashby MA, Dong W, Sugrue MM, Grothey A, Investigators of the BRiTE Study (2009) Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort study. Oncologist. 2009; 14(9): 862-70.
20. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999; 230(3): 309-18.